ReleaseWire Connect

This report covers the market analysis for various devices used for diagnosing and monitoring of cardiovascular diseases. The stakeholders for this study include the present manufacturers and providers of cardiovascular diagnostic and monitoring devices as well as the new players who desire to enter this market.

High demand for steel manufacturing and steel processing along with recycling has been driving the market for silicon carbide (SiC) in the past few years. Silicon carbide is a key component of the semiconductor devices and growth in the electronics and semiconductor market is also a driving factor governing SiC market growth. The high precision required for manufacturing components and the low level of tolerances in the end-user market have been restraining the market at the same time.

Gobal Safety Syringes Market was valued at USD 3.41 billion in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value of USD 6.50 billion by 2019.

Home Automation Market was valued at USD 3.6 billion in 2012 and is expected to reach USD 16.4 billion by 2019, growing at a CAGR of 24.6% from 2013 to 2019.

Most up-to-date research on "e-Therapeutics plc - Product Pipeline Review - 2014" to its huge collection of research reports.

Most up-to-date research on "Cadila Pharmaceuticals Ltd. - Product Pipeline Review - 2014" to its huge collection of research reports.

Most up-to-date research on "PharmaPoint: Major Depressive Disorder - US Drug Forecast and Market Analysis to 2023" to its huge collection of research reports.

The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.

MediPoint: Spinal Fusion - Global Analysis and Market Forecasts

United States Cardiovascular Procedures Outlook to 2020